ArticleFuture oncology (London, England)2017
End points and statistical considerations in immuno-oncology trials: impact on multiple myeloma.
Antje Hoering et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it